•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

Instructions: RRB-Boutique Indo-Thai hotels: Amss-AZB | Rs 2000 cr IndusInd QIP: Crawford-S&R | Rs 600 cr PC Jewellers IPO: AMSS-S&R | SBI, ICICI Rs 1600 cr CDR: KhaiCo | Hospira-Orchid at CCI: Khaico

Last package from '12
Last package from '12

Amarchand, AZB, Khaitan, Crawford Bayley and S&R Associates wrap up the last five deals of 2012..

Corporate/M&A and joint venture

Thailand-based hospitality group RRB entered into three Hotel Management Agreements with Boutique Hotels India for managing and operating three luxury hotels in India under the brandname ‘lebua’
RRB Group: Amarchand Mangaldas Delhi partner Akila Agrawal with principal associate Sourav Kanti De Biswas and senior associate Mukul Sharma
Boutique Hotels: AZB & Partners Delhi partner Hardeep Sachdeva

Capital Markets
Private sector lender IndusInd Bank did a qualified institutional placement of Rs 2000 crore ($36.8m) , with investment banks Morgan Stanley, JM Financial, CLSA and HSBC as the book running lead managers (BRLM)
BRLM: S&R Associates co-founding partner Sandip Bhagat and Delhi partner Venkatesh Vijayaraghavan, with associates Jabarati Chandra, Amy Bharucha, and Reeba Muthalaly, with Dorsey & Whitney LLP
IndusInd Bank: Crawford Bayley Mumbai

Delhi-based jewellery company PC Jewellers made an initial public offering worth Rs 600 crore, with SBI Capital Markets and Kotak Mahindra as the underwriters

PC Jewellers: Amarchand Mangaldas Delhi capital markets partner Prashant Gupta
Underwriters: S&R Associates partners Juhi Singh and Bhakta Patnaik, with associates Ganeev Dhillon, Brajendu Bhaskar, and Rohit Anand, with DLA Piper Singapore


Banking and finance

IL&FS Engineering & Construction Company borrowed Rs 1630 crore from a consortium of CDR lenders led by State Bank of India and ICICI Bank which enhanced the existing working capital limits from Rs 1277 crore
Lenders: Khaitan & Co Mumbai partner Shishir Mehta
IL&FS: In-house

Leading global injectable drugs maker Hospira’s Indian subsidiary Hospira Healthcare India (HHI) and Chennai-based global pharma major Orchid, which had been bought by HHI in August, modified the term of the non-compete obligation in their Business Transfer Agreement, the amended form of which they will submit to the Competition Commission of India (CCI)
Hospira: Khaitan & Co Mumbai competition law counsel Avaantika Kakkar

If you would like your deals included in future deals round-ups, please send us an email at with details of the transaction and lead partners.

Click to show 1 comment
at your own risk
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.